Company & Sponsor Intelligence

Oslo University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting1

Completed1

Countries1

Therapeutic footprint

adhdalzheimersintellectual_disabilityneuro_oncology

Indexed studies

NCT06234436Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)
alzheimers · NorwayEARLY_PHASE1

NCT05049356Symptoms and Mechanisms of Child Psychiatric Disorders
adhd · NorwayUNKNOWN

NCT05190172PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
neuro_oncology · NorwayNA

NCT03768674Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway
intellectual_disability · NorwayCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →